Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-14-007759)

Filing Details

Accession Number:: 0001209191-14-007759
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-02-05 19:50:03
Reporting Period:: 2014-02-03

Filing Date:: 2014-02-05
Accepted Time:: 2014-02-05 19:50:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1087432	Intermune Inc	ITMN	Pharmaceutical Preparations (2834)	943296648

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1206199	G Daniel Welch	3280 Bayshore Boulevard Brisbane CA 94005	Chairman, Ceo And President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-02-03	20,000	$13.08	117,434	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The transaction was made pursuant to the terms of the 10b5-1 plan in effect at the time of the transaction.
Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $12.96 to $13.49 per share. Full information on the numbers of shares sold at each sale price is available upon request.